Accuray (ARAY) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.44% |
| Dec 31, 2025 | 0.96% |
| Sep 30, 2025 | 1.94% |
| Jun 30, 2025 | 38.26% |
| Mar 31, 2025 | 2.61% |
| Dec 31, 2024 | 3.29% |
| Sep 30, 2024 | 2.54% |
| Jun 30, 2024 | -28.57% |
| Mar 31, 2024 | -0.41% |
| Dec 31, 2023 | -15.08% |
| Sep 30, 2023 | -25.19% |
| Jun 30, 2023 | -22.48% |
| Mar 31, 2023 | 3.41% |
| Dec 31, 2022 | 2.72% |
| Sep 30, 2022 | -23.40% |
| Jun 30, 2022 | -24.92% |
| Mar 31, 2022 | -0.24% |
| Dec 31, 2021 | 5.85% |
| Sep 30, 2021 | -37.69% |
| Jun 30, 2021 | -39.55% |
| Mar 31, 2021 | -0.52% |
| Dec 31, 2020 | -2.20% |
| Sep 30, 2020 | -0.98% |
| Jun 30, 2020 | -47.87% |
| Mar 31, 2020 | 0.41% |
| Dec 31, 2019 | 0.14% |
| Sep 30, 2019 | 1.69% |
| Jun 30, 2019 | 2.86% |
| Mar 31, 2019 | 1.22% |
| Dec 31, 2018 | 1.79% |
| Sep 30, 2018 | 4.57% |
| Jun 30, 2018 | 6.03% |
| Mar 31, 2018 | 7.19% |
| Dec 31, 2017 | 5.22% |
| Sep 30, 2017 | 1.91% |
| Jun 30, 2017 | 2.20% |
| Mar 31, 2017 | -0.90% |
| Dec 31, 2016 | -3.84% |
| Sep 30, 2016 | -2.94% |
| Jun 30, 2016 | 53.62% |
| Mar 31, 2016 | 13.97% |
| Dec 31, 2015 | 14.96% |
| Sep 30, 2015 | 18.68% |